Skip to main content

Ophthalmic Drugs Market Growth & Strategy Framework To 2020

In December 2017, Spark Therapeutics received Food and Drug Administration (FDA) approval for the first gene therapy drug in the ophthalmic market-Luxturna (voretigene neparvovec-rzyl). The drug is indicated for ophthalmic diseases associated with RPE65 gene mutation, such as retinitis pigmentosa and Leber’s congenital amaurosis.

Download Free PDF Sample  - https://www.radiantinsights.com/research/ophthalmic--drugs-market/request-sample

Increasing number of strategic mergers, acquisitions, and collaborations make the market for ophthalmic drugs a highly competitive space. However, there is ample scope for consolidation. Premium services and high-volume ancillary value-added businesses deliver supplementary benefits to customers and attract investments in the market. The reimbursement policies for ophthalmic treatment form a diversifying factor in the market.

Companies are constantly launching new products to expand their product portfolio and to attain higher share. For instance, in July 2019, Bausch & Lomb Incorporated announced launch of Ocuvite, an eye vitamin supplement to strengthen the macula for the U.S. market.

Due to increasing awareness of ophthalmic disorders and surge in the demand of these products, ophthalmic drug manufacturers are expanding their presence in the emerging economies by supporting various awareness campaigns in different regions. For instance, in 2016, Alcon announced their support to a public awareness program, Think About Your Eyes. The company committed USD 4 million to support this initiative and to promote awareness pertaining to vision care.

Browse Full Report With TOC  - https://www.radiantinsights.com/research/ophthalmic--drugs-market

Further key findings from the study suggest:

• Anti-VEGF agents dominated the drug class segment in 2019 and is anticipated to register the fastest CAGR of 6.7% over the forecast period

• Retinal disorder held the largest market share in 2019 due to rising prevalence of diabetic retinopathy

• In 2019, macular degeneration was the largest retinal disorder segment and diabetic retinopathy was the fastest growing segment

• Eye drops held the leading ophthalmic drugs market share in 2019 and is projected to witness the highest CAGR during the forecast period as it is the most preferred form of drug delivery used for treating ocular diseases such as acute allergies, corneal ulcers, and glaucoma

Comments

Post a Comment

Popular posts from this blog

Thermal Spray Coatings Market Share & Scope, Product Estimates & Strategy Framework To 2013 - 2024

Thermal spray coating refers to industrial process that involves coating material in wire or powder form and a heat source. The heat source is used to melt the material into tiny droplets, which are sprayed onto substrates at high velocity. This technique is able to improve performance characteristics of the substrates by imparting erosion, wear, corrosion, heat, cavitation, and abrasion. Other advantages include high deposition rate, thick coatings, and low toxic gas emissions. Growing need to enhance durability of machines among industries to reduce maintenance costs is anticipated to propel thermal spray coatings industry growth. Changing consumer preference for thermal spray coatings over chrome plating owing to superior properties is expected to impel market growth. Stringent regulations introduced by governments across various nations to reduce use of material containing volatile organic compounds (VOCs) will drive the thermal spray coatings market over the forecast period. Downl
Post a Comment
Read more

Global DHA from Algae Market Size Comparison by Application (2013-2028)

    The global DHA from Algae market was valued at $XX million in 2018, and Radiant Insights analysts predict the global market size will reach $XX million by the end of 2028, growing at a CAGR of XX% between 2018 and 2028. This report provides detailed historical analysis of global market for DHA from Algae from 2013-2018, and provides extensive market forecasts from 2019-2028 by region/country and subsectors. It covers the sales volume, price, revenue, gross margin, historical growth and future perspectives in the DHA from Algae market. Download Free Sample  -  https://www.radiantinsights.com/research/2013-2028-report-on-global-dha-from-algae-market/request-sample Leading players of DHA from Algae including: DSM Lonza Cellana JC Biotech FEMICO Runke Bioco CABIO Fuxing Huison Kingdomway Amry Yuexiang Keyuan Market split by Type, can be divided into: Triglyceride Type Ester Type Ethyl Ester Type Market split by Application, can be divided into: Infant Formula Nutritional Supplements Fo
Post a Comment
Read more

Cyclospora Diagnostic Testing Market Size & Forecast Report, 2014 - 2025

Cyclospora is basically an intestinal ailment that is affected via the microscopic parasite termed as “Cyclospora cayetanensis”. Cyclospora Diagnostic Testing Market size on the basis of end-users spans commercial or private laboratories, hospitals, public health labs and physician offices. It is a single-celled coccidian parasitic pathogen that triggers intestinal infection that leads to diarrhea. When we look at it in the medical terms, this diarrheal infection is labeled as cyclospora infection (cyclosporiasis). It is known that this particular infection is usually spread and communicated via feces and ingestion of food and water infected with sporulated oocysts. Download Free Sample  -  https://www.millioninsights.com/industry-reports/cyclospora-diagnostic-testing-market/request-sample Through studies, it has been found that people can be infected with Cyclospora by taking in food or water that is polluted and tainted with the parasite. Those people are at great risk for infection
Post a Comment
Read more